Source: PaxForex Premium Analytics Portal, Fundamental Insight Last year was characterized by a tightening of monetary policy as higher interest rates were introduced to combat rising inflation. As a result, investors became disillusioned with risky assets, including growth stocks and cryptocurrencies. Even bitcoin suffered a crushing defeat, falling 65% in 2022. But things may be changing for the better, as bitcoin jumped 37% in January. Can this cryptocurrency reach the $100,000 per coin mark? At less than $23,000, this price target...
Source: PaxForex Premium Analytics Portal, Fundamental Insight Australian TD Securities Inflation for January increased by 0.9% monthly. Forex traders can compare this to Australian TD Securities Inflation for December, which rose 0.2% monthly. Australia is one of the first countries feeling the impact of the Chinese re-opening of their economy, and the rise in inflation is a sign of what traders should expect throughout 2023 until a global recession can dampen inflationary pressures. Otherwise, a long period of stagflation could manifest...
Source: PaxForex Premium Analytics Portal, Fundamental Insight The previous several years have been petty tough for e-commerce giant Alibaba Group, to say the least. After peaking amid the coronavirus pandemic, the company lost nearly 80% of its value over the next two years. Since then, the company has rallied, up 78% from its October 2022 low, but still a far cry from the levels that preceded the COVID-19 pandemic. Needless to say, these have been challenging times for Alibaba and its investors. And while the company still has a...
Source: PaxForex Premium Analytics Portal, Fundamental Insight Singapore Retail Sales for December rose by 1.3% monthly and 7.4% annualized. Forex traders can compare this to Singapore Retail Sales for November, which contracted by 3.6% monthly and increased by 6.5% annualized. The US NFP Report for January is predicted to show 185K job additions and an unemployment rate of 3.6%. Forex traders can compare this to the US NFP Report for December, which showed 223K job additions and an unemployment rate of 3.5%. Private Payrolls for January...
Source: PaxForex Premium Analytics Portal, Fundamental Insight When major U.S. stock indices plunged into bear territory in 2022, big pharma stocks quickly became an oasis for nervous investors in many cases because of their largely recession-proof business models, solid cash flows, and steady quarterly dividends. Most pharmaceutical companies outperformed the broader markets last year. One rare exception to this trend was Pfizer. The stock of this drug maker fell 10.4% last year, despite the company's impressive earnings growth...